SS-31 vs Glutathione
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Elamipretide, Bendavia
SS-31 (sequence D-Arg-Dmt-Lys-Phe-NH2), known generically as elamipretide and sold as FORZINITY, is a synthetic tetrapeptide that homes in on the energy-producing machinery inside your cells. It works by binding cardiolipin, a fat unique to the inner mitochondrial membrane, to help mitochondria run cleaner and make more ATP with less oxidative damage. This is the rare research peptide with a real regulatory finish line: the FDA granted it accelerated approval in September 2025 for Barth syndrome, though it has failed several other major trials.
Also: L-Glutathione, GSH
Glutathione is the body's main intracellular antioxidant, a tripeptide of glutamate, cysteine, and glycine (often written GSH). It is sold as oral, IV, topical, and inhaled products and marketed for everything from detox and immune support to skin lightening, but its real, evidence-backed role is as a redox buffer that neutralizes oxidative stress and supports liver detoxification. Some clinical evidence exists for specific uses, while many popular claims, especially IV skin whitening, rest on weak or risky data.
Key Comparison Insights
- SS-31 is FDA approved, while Glutathione remains in research stages.
- Both peptides belong to the Anti-Aging category, suggesting similar primary applications.
- SS-31 has stronger research evidence (FDA Approved) compared to Glutathione (Human Trials).
Detailed Comparison
| Attribute | SS-31 | Glutathione |
|---|---|---|
| Category | Anti-Aging | Anti-Aging |
| FDA Status | FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | SS-31 is a cell-permeable, mitochondria-targeted peptide that concentrates in the inner mitochondrial membrane and binds tightly to cardiolipin. Cardiolipin is essential for keeping the membrane's folded cristae structure intact and for organizing the proteins of the electron transport chain that generate ATP. By stabilizing cardiolipin, SS-31 helps preserve cristae shape, reduces the electron leakage that produces reactive oxygen species, and supports more efficient ATP production. Studies also suggest it modulates the membrane's surface electrostatics and can limit opening of the mitochondrial permeability transition pore, a trigger for cell death, though the full mechanistic picture is still being worked out. | Glutathione works by donating electrons to neutralize reactive oxygen species and free radicals, cycling between its reduced (GSH) and oxidized (GSSG) forms with the help of enzymes like glutathione peroxidase and glutathione reductase. It also conjugates toxins and drug metabolites in the liver (phase II detoxification) so they can be excreted, and it regenerates other antioxidants such as vitamins C and E. For skin lightening specifically, the proposed mechanism is inhibition of tyrosinase, the enzyme that makes melanin, and a shift from darker eumelanin toward lighter pheomelanin. A practical catch with oral glutathione is that much of it is broken down in the gut, which is why precursors like N-acetylcysteine are sometimes used to raise levels instead. |
| Common Dosing | 40 mg subcutaneous daily Once daily | 500-1000 mg daily (oral or liposomal) 1-2x daily |
| Administration | Subcutaneous injection or IV infusion | Oral, liposomal, IV, or subcutaneous |
| Typical Duration | Variable by condition | Ongoing supplementation or 4-12 week courses |
| Best Time to Take | Morning | Morning on empty stomach, or evening |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Unlike most peptides in this space, SS-31 has been through extensive human trials, with a mixed but consequential record. In TAZPOWER, a randomized placebo-controlled crossover study in Barth syndrome, elamipretide improved skeletal muscle strength and cardiac stroke volume, and the long open-label extension showed sustained benefit, which ultimately supported FDA accelerated approval in September 2025 as the first treatment for that ultra-rare disease. It has also failed prominently: the Phase 3 MMPOWER-3 trial in primary mitochondrial myopathy missed its primary endpoints on the six-minute walk test, the ReCLAIM trial in dry age-related macular degeneration did not hit its primary endpoints, and a heart-failure trial (PROGRESS-HF) also missed its primary endpoint. Across these studies the drug was generally well tolerated, with mostly mild effects such as injection-site reactions, headache and nausea. The accurate summary is that SS-31 is a validated mitochondrial-targeting peptide with one approved indication and a string of negative trials elsewhere, so its benefit appears to depend heavily on the specific disease. | Glutathione has genuine human evidence for some uses and shaky evidence for others. A six-month randomized trial of 500 mg/day oral glutathione in elderly type 2 diabetics found a large reduction in the DNA oxidative-damage marker 8-OHdG and a modest improvement in HbA1c, supporting its antioxidant role. For skin lightening, several small randomized trials of oral glutathione (250 to 500 mg/day) reported significant but variable reductions in melanin index versus placebo, and a 2025 systematic review concluded effects are real but modest and inconsistent. Intravenous glutathione for whitening is the weakest and riskiest application: there is essentially one placebo-controlled study, no standardized dosing, and documented reports of serious adverse events, prompting the Philippine FDA to warn against off-label IV use. Glutathione is also used clinically as supportive care, for example IV protocols studied for chemotherapy-induced neuropathy, with mixed results. Bottom line: solid as an antioxidant, plausible but modest for oral skin lightening, and not justified as high-dose IV whitening given the safety concerns. |
Frequently Asked Questions: SS-31 vs Glutathione
What is the difference between SS-31 and Glutathione?
SS-31 is a anti-aging peptide that ss-31 (sequence d-arg-dmt-lys-phe-nh2), known generically as elamipretide and sold as forzinity, is a synthetic tetrapeptide that homes in on the energy-producing machinery inside your cells. it works by binding cardiolipin, a fat unique to the inner mitochondrial membrane, to help mitochondria run cleaner and make more atp with less oxidative damage. this is the rare research peptide with a real regulatory finish line: the fda granted it accelerated approval in september 2025 for barth syndrome, though it has failed several other major trials. Glutathione is a anti-aging peptide that glutathione is the body's main intracellular antioxidant, a tripeptide of glutamate, cysteine, and glycine (often written gsh). it is sold as oral, iv, topical, and inhaled products and marketed for everything from detox and immune support to skin lightening, but its real, evidence-backed role is as a redox buffer that neutralizes oxidative stress and supports liver detoxification. some clinical evidence exists for specific uses, while many popular claims, especially iv skin whitening, rest on weak or risky data. The main differences lie in their mechanisms of action and clinical applications.
Which is better, SS-31 or Glutathione?
Neither is universally "better" - the choice depends on your specific goals. SS-31 is typically used for anti-aging purposes, while Glutathione is used for anti-aging. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can SS-31 and Glutathione be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using SS-31 and Glutathione together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.